Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Consumer-grade wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis

View ORCID ProfileAnoopum S. Gupta, Siddharth Patel, Alan Premasiri, Fernando Vieira
doi: https://doi.org/10.1101/2023.03.28.23287869
Anoopum S. Gupta
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anoopum S. Gupta
  • For correspondence: agupta{at}mgh.harvard.edu
Siddharth Patel
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Premasiri
2ALS Therapy Development Institute, Watertown, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Vieira
2ALS Therapy Development Institute, Watertown, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

ALS causes degeneration of motor neurons, resulting in progressive muscle weakness and impairment in fine motor, gross motor, bulbar, and respiratory function. Promising drug development efforts have accelerated in ALS, but are constrained by a lack of objective, sensitive, and accessible outcome measures. Here we investigate the use of consumer-grade wearable sensors, worn on four limbs at home during natural behavior, to quantify motor function and disease progression in 376 individuals with ALS over a several year period. We utilized an analysis approach that automatically detects and characterizes submovements from passively collected accelerometer data and produces a machine-learned severity score for each limb that is independent of clinical ratings. The approach produced interpretable and highly reliable scores that progressed faster than the gold standard ALS Functional Rating Scale-Revised (−0.70 SD/year versus -0.48 SD/year), supporting its use as a sensitive, ecologically valid, and scalable measure for ALS trials and clinical care.

Competing Interest Statement

For the methods for analyzing wearable sensor data, a PCT (US2022/081374) was filed on December 12, 2022, titled: System and method for clinical disorder assessment. An earlier US Provisional Application (Serial No. 63/288,619) was filed on December 12, 2021.

Funding Statement

This work was funded in part by NIH R01 NS117826.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This research study was conducted in accordance with the ethical principles posited in the Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Protocol approval was provided by the institutional review board (ADVARRA CIRBI). Every participant consented to participate in this research by signing an IRB approved informed consent form.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

Data included in this study will be shared by request from any qualified investigator.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 30, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Consumer-grade wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Consumer-grade wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis
Anoopum S. Gupta, Siddharth Patel, Alan Premasiri, Fernando Vieira
medRxiv 2023.03.28.23287869; doi: https://doi.org/10.1101/2023.03.28.23287869
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Consumer-grade wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis
Anoopum S. Gupta, Siddharth Patel, Alan Premasiri, Fernando Vieira
medRxiv 2023.03.28.23287869; doi: https://doi.org/10.1101/2023.03.28.23287869

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)